Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N- (2-hydroxypropyl) methacrylamide copolymers
- 1 June 1991
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 16 (1-2), 121-136
- https://doi.org/10.1016/0168-3659(91)90036-d
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of molecular weight (Mw) ofN‐(2‐hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to ratsJournal of Biomedical Materials Research, 1987
- Interplay Between the Toxic Effects of Anticancer Drugs and Host Antitumor Immunity in Cancer TherapyCancer Investigation, 1987
- Stability of Melphalan Solutions During Preparation and StorageJournal of Pharmaceutical Sciences, 1985
- Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymersBiomaterials, 1985
- Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymersBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Comparison of antitumor effects of daunorubicin covalently linked to poly-l-amino acid carriersEuropean Journal of Cancer and Clinical Oncology, 1984
- Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustardJournal of Medicinal Chemistry, 1983
- Identification of the active site cysteine and of the disulfide bonds in the N‐terminal part of the molecule of bovine spleen cathepsin BFEBS Letters, 1982
- Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers a potential drug delivery systemBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- FAILURE TO INCREASE THE IN VIVO IMMUNOSUPPRESSIVE ACTIVITY OF ANTILYMPHOCYTE GLOBULIN BY CONJUGATION WITH MELPHALANTransplantation, 1980